BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8874720)

  • 1. Temporal variation and factors affecting measurement of canine von Willebrand factor.
    Moser J; Meyers KM; Meinkoth JH; Brassard JA
    Am J Vet Res; 1996 Sep; 57(9):1288-93. PubMed ID: 8874720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inheritance of von Willebrand factor deficiency in Doberman pinschers.
    Moser J; Meyers KM; Russon RH
    J Am Vet Med Assoc; 1996 Sep; 209(6):1103-6. PubMed ID: 8800256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Willebrand factor is not altered in azotemic dogs with prolonged bleeding time.
    Brassard JA; Meyers KM
    J Lab Clin Med; 1994 Jul; 124(1):55-62. PubMed ID: 8035104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma von Willebrand factor changes during various reproductive cycle stages in mixed-breed dogs with normal von Willebrand factor and in Doberman pinschers with type-I von Willebrand's disease.
    Moser J; Meyers KM; Russon RH; Reeves JJ
    Am J Vet Res; 1998 Jan; 59(1):111-8. PubMed ID: 9442254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Content and functional activity of von Willebrand factor in apheresis plasma.
    Burnouf T; Caron C; Burkhardt T; Goudemand J
    Vox Sang; 2004 Jul; 87(1):27-33. PubMed ID: 15260819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Von Willebrand factor concentrations in blood plasma of Bernese mountain dogs].
    Arnold S; Müller A; Binder H; Meyers K; Giger U
    Schweiz Arch Tierheilkd; 1997; 139(4):177-82. PubMed ID: 9173518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a collagen-binding activity assay as a screening test for type II von Willebrand disease in dogs.
    Sabino EP; Erb HN; Catalfamo JL
    Am J Vet Res; 2006 Feb; 67(2):242-9. PubMed ID: 16454628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use.
    Murdock PJ; Woodhams BJ; Matthews KB; Pasi KJ; Goodall AH
    Thromb Haemost; 1997 Oct; 78(4):1272-7. PubMed ID: 9364997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma von Willebrand factor in thoroughbreds in response to high-intensity treadmill exercise.
    Smith JM; Meyers KM; Barbee DD; Schott H; Bayly WM
    Am J Vet Res; 1997 Jan; 58(1):71-6. PubMed ID: 8989500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An interobserver and intraobserver study of buccal mucosal bleeding time in Greyhounds.
    Sato I; Anderson GA; Parry BW
    Res Vet Sci; 2000 Feb; 68(1):41-5. PubMed ID: 10684757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential distribution of von Willebrand factor in canine vascular endothelium.
    Smith JM; Meinkoth JH; Hochstatter T; Meyers KM
    Am J Vet Res; 1996 May; 57(5):750-5. PubMed ID: 8723894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement.
    Lippi G; Franchini M; Targher G; Poli G; Guidi GC
    Clin Chim Acta; 2007 Jun; 381(2):167-70. PubMed ID: 17433810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality.
    Catto AJ; Carter AM; Barrett JH; Bamford J; Rice PJ; Grant PJ
    Thromb Haemost; 1997 Jun; 77(6):1104-8. PubMed ID: 9241740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of the factor VIII/von Willebrand factor concentrate, haemate-P/humate-P: ristocetin cofactor unit dosing in patients with von Willebrand disease.
    Lillicrap D; Poon MC; Walker I; Xie F; Schwartz BA;
    Thromb Haemost; 2002 Feb; 87(2):224-30. PubMed ID: 11858481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
    Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor.
    Casonato A; Pontara E; Bertomoro A; Cattini MG; Soldera C; Girolami A
    Haematologica; 2003 Jun; 88(6):688-93. PubMed ID: 12801845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of coagulation test results for blood samples obtained by means of direct venipuncture and through a jugular vein catheter in clinically normal dogs.
    Millis DL; Hawkins E; Jager M; Boyle CR
    J Am Vet Med Assoc; 1995 Nov; 207(10):1311-4. PubMed ID: 7591925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor in diabetic retinopathy.
    Abayomi EA; Miller E; Paton RC
    Cent Afr J Med; 1996 Jul; 42(7):205-6. PubMed ID: 8936786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of time and dilution on concentration of xanthine in frozen urine and plasma of dogs.
    Bartges JW; Osborne CA; Felice LJ; Chen M; Ulrich LK
    Am J Vet Res; 1997 Feb; 58(2):118-20. PubMed ID: 9028471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.